Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer.
Biomed Pharmacother
; 163: 114732, 2023 Jul.
Article
in En
| MEDLINE
| ID: mdl-37254289
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cytokine-Induced Killer Cells
/
Triple Negative Breast Neoplasms
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Biomed Pharmacother
Year:
2023
Document type:
Article
Country of publication:
France